CORBION NV (CRBN.AS) Stock Fundamental Analysis
AMS:CRBN - Euronext Amsterdam - NL0010583399 - Common Stock - Currency: EUR
Overall CRBN gets a fundamental rating of 6 out of 10. We evaluated CRBN against 62 industry peers in the Chemicals industry. CRBN scores excellent on profitability, but there are some minor concerns on its financial health. CRBN scores decently on growth, while it is valued quite cheap. This could make an interesting combination. This makes CRBN very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year CRBN was profitable.
CRBN had a positive operating cash flow in the past year.
In the past 5 years CRBN has always been profitable.
In the past 5 years CRBN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of CRBN (12.43%) is better than 100.00% of its industry peers.
Looking at the Return On Equity, with a value of 24.88%, CRBN belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.89%, CRBN is doing good in the industry, outperforming 77.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 6.15%.
The last Return On Invested Capital (6.89%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROIC | 6.89% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
1.3 Margins
CRBN has a better Profit Margin (14.92%) than 93.55% of its industry peers.
In the last couple of years the Profit Margin of CRBN has grown nicely.
The Operating Margin of CRBN (7.04%) is better than 67.74% of its industry peers.
In the last couple of years the Operating Margin of CRBN has declined.
CRBN has a Gross Margin (24.81%) which is in line with its industry peers.
CRBN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% |
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRBN is still creating some value.
Compared to 1 year ago, CRBN has less shares outstanding
Compared to 5 years ago, CRBN has less shares outstanding
CRBN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.56 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CRBN (2.56) is better than 66.13% of its industry peers.
CRBN has a debt to FCF ratio of 5.10. This is a neutral value as CRBN would need 5.10 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.10, CRBN is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
CRBN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CRBN (0.40) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.56 |
ROIC/WACC1.06
WACC6.48%
2.3 Liquidity
A Current Ratio of 1.17 indicates that CRBN should not have too much problems paying its short term obligations.
CRBN has a Current ratio of 1.17. This is in the lower half of the industry: CRBN underperforms 77.42% of its industry peers.
A Quick Ratio of 0.58 indicates that CRBN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.58, CRBN is doing worse than 87.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 168.39% over the past year.
CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
Looking at the last year, CRBN shows a small growth in Revenue. The Revenue has grown by 1.90% in the last year.
The Revenue has been growing slightly by 5.70% on average over the past years.
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
3.2 Future
Based on estimates for the next years, CRBN will show a very strong growth in Earnings Per Share. The EPS will grow by 27.50% on average per year.
The Revenue is expected to grow by 3.97% on average over the next years.
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue Next Year3.15%
Revenue Next 2Y3.69%
Revenue Next 3Y3.97%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.71, which indicates a rather cheap valuation of CRBN.
98.39% of the companies in the same industry are more expensive than CRBN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.98. CRBN is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.87, which indicates a very decent valuation of CRBN.
Based on the Price/Forward Earnings ratio, CRBN is valued cheaply inside the industry as 82.26% of the companies are valued more expensively.
CRBN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 11.87 |
4.2 Price Multiples
CRBN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CRBN is cheaper than 66.13% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CRBN is valued cheaper than 80.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.83 | ||
| EV/EBITDA | 8.71 |
4.3 Compensation for Growth
CRBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CRBN may justify a higher PE ratio.
A more expensive valuation may be justified as CRBN's earnings are expected to grow with 27.50% in the coming years.
PEG (NY)0.1
PEG (5Y)0.12
EPS Next 2Y34.31%
EPS Next 3Y27.5%
5. Dividend
5.1 Amount
CRBN has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
CRBN's Dividend Yield is a higher than the industry average which is at 3.07.
Compared to an average S&P500 Dividend Yield of 2.46, CRBN pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
5.3 Sustainability
21.80% of the earnings are spent on dividend by CRBN. This is a low number and sustainable payout ratio.
CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP21.8%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
AMS:CRBN (4/29/2025, 7:00:00 PM)
18.57
-0.07 (-0.38%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners77.4%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts78.46
Price Target26.08 (40.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP21.8%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.79%
PT rev (3m)-5.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.41%
EPS NY rev (3m)3.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.93%
Revenue NY rev (3m)-1.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.71 | ||
| Fwd PE | 11.87 | ||
| P/S | 0.84 | ||
| P/FCF | 10.83 | ||
| P/OCF | 5.88 | ||
| P/B | 1.4 | ||
| P/tB | 1.61 | ||
| EV/EBITDA | 8.71 |
EPS(TTM)3.25
EY17.5%
EPS(NY)1.56
Fwd EY8.42%
FCF(TTM)1.72
FCFY9.24%
OCF(TTM)3.16
OCFY17.02%
SpS22.11
BVpS13.26
TBVpS11.56
PEG (NY)0.1
PEG (5Y)0.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.43% | ||
| ROE | 24.88% | ||
| ROCE | 8.18% | ||
| ROIC | 6.89% | ||
| ROICexc | 7.21% | ||
| ROICexgc | 7.95% | ||
| OM | 7.04% | ||
| PM (TTM) | 14.92% | ||
| GM | 24.81% | ||
| FCFM | 7.76% |
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexcg growth 3Y0.82%
ROICexcg growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score8
Asset Turnover0.83
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 1.73 | ||
| Cap/Depr | 97% | ||
| Cap/Sales | 6.54% | ||
| Interest Coverage | 3.61 | ||
| Cash Conversion | 103.72% | ||
| Profit Quality | 51.98% | ||
| Current Ratio | 1.17 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.56 |
F-Score8
WACC6.48%
ROIC/WACC1.06
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168.39%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-47.64%
EPS Next Y55.4%
EPS Next 2Y34.31%
EPS Next 3Y27.5%
EPS Next 5YN/A
Revenue 1Y (TTM)1.9%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%4.6%
Revenue Next Year3.15%
Revenue Next 2Y3.69%
Revenue Next 3Y3.97%
Revenue Next 5YN/A
EBIT growth 1Y44.66%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year147.92%
EBIT Next 3Y43.91%
EBIT Next 5YN/A
FCF growth 1Y520.5%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y11.31%
OCF growth 3Y101.81%
OCF growth 5Y9.98%